AACE/ACE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM —— $——— Martin. Abrahamson, MD Joshua | Barilay, MO, FACE Lawrence Blonde, MD, FACP, FACE Zachary. Bleomgarden, MD, MACE Michael A. Bush, MD ‘Samuel Dagogo-Jack, MD, DM, FRCP, FACE Ralph A. Defronzo, MD TASK FORCE Alan J. Garber, MD, PhD, FACE, Chair Daniel Einhorn, MD, FACP, FACE Vivian A. Fonseca, MO, FACE Jerey R. Garber, MD, FACE, FACE Wi. Timothy Garvey, MO, FACE George Grunberger, MO, FACP, FACE ‘Yehuda Handelsman, MO, FACE, FNLA, FACE Robert R Henry, MD, FACE Ie B. Hirsch, MD Paul Selinger, MD, MACE Janet B. McGill, MD, FACE Jeffrey | Mechanick, MD, FACE FACE, FACN, ECNU Paul D Rosenbli, MD, PhO, FNLA, FACE Guillermo Umpierrez, MO, FACP, FACETABLE OF CONTENTS COMPREHENSIVE TYPE 2 DIABETES ALGORITHM VI. VIL. VIL. IX, LIFESTYLE THERAPY COMPLICATIONS-CENTRIC MODEL FOR CARE OF THE OVERWEIGHT/OBESE PATIENT PREDIABETES ALGORITHM GOALS FOR GLYCEMIC CONTROL GLYCEMIC CONTROL ALGORITHM ALGORITHM FOR ADDING/INTENSIFYING INSULIN ASCVD RISK FACTOR MODIFICATIONS ALGORITHM PROFILES OF ANTIDIABETIC MEDICATIONS PRINCIPLES FOR TREATMENT OF TYPE 2 DIABETESfae) peng Ce) as ‘Smoking rrr ORSINI): ise wag RISK STRATIFICATION FOR DIAB Maintain optimal weight Calorie restriction Plant-based dit; high polyunsaturated and monounsaturated faty aids ‘Avoid trans faty acids limit saturated fatty acids 150 min/week moderate exertion (eg. walking stair climbing) Strength training Increace as tolerated About 7 hours per night Community engagement Sereen for mood disorders No tobacco products TES Teron nu ar Structured counseling Meal replacement Medical evaluation! clearance Medical supervision structured program Screen for obstructive sleep apnea Refer to mental healthcare professional Behavioral therapy, Structured programs